Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Venous Thrombosis × edoxaban × Clear all

Phase

Phase NA 2 Phase 3 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Venous Thrombosis 1 Thromboembolism 1

Interventions

edoxaban 1 apixaban 1 Rivaroxaban 1 Heparin, Low-Molecular-Weight 1 Fluorodeoxyglucose F18 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03895502 2023-10-04

ONCO DVT

Kyoto University, Graduate School of Medicine

Phase 4 Completed

Neoplasms, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡